Following with the mentioned study, our study showed that the SPAP in the patient group was approximately 1.7 times that of the control group, indicating the presence of pulmonary hypertension in a significant proportion of SSc patients. The gene discussed is PDZK1IP1; the disease is pulmonary hypertension.